Thousands of people at higher risk of developing cancer due to inherited faulty genes will be regularly checked and tracked by the NHS thanks to a first-of-its-kind national genetics programme.
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
Hybrid working – allocated to offices in Coventry or York £30,253 - £36,117 per annum
Maidenhead, Berkshire£47,831 - £52,414 per annum
Hybrid working – allocated to offices in Coventry or York £30,253 - £36,117 per annum
Maidenhead, Berkshire£47,831 - £52,414 per annum